Evotec has partnered with Hypha Discovery to give screening clients access to Hypha's Mycodiverse natural product collection for use as part of its hit-and-lead identification services.
Following screening, Evotec could leverage its capabilities in natural product chemistry and medicinal chemistry to optimise promising hit compounds.
The Mycodiverse collection, which is unexploited in most therapeutic areas, contains samples of high chemical novelty.
This, allied with Evotec's proprietary technologies in assay development, screening and medicinal chemistry, is claimed to create a comprehensive platform for lead generation via natural product screening.
